Organization
Albany Medical College
5 clinical trials
9 abstracts
Clinical trial
Effect of Non-steroidal Anti-inflammatory Drugs on Serum Prostate Specific Antigen LevelStatus: Recruiting, Estimated PCD: 2024-09-01
Abstract
Examining the risk factors for trastuzumab-related cardiotoxicity in a predominantly Hispanic South Texas population: A descriptive study.Org: Division of General Medical Sciences, Albany Medical College,
Clinical trial
Efficacy of Rescue Surfactant Delivery Via Endotracheal Intubation (INSURE Technique) Versus Laryngeal Mask Airway (LMA) for Respiratory Distress Syndrome (RDS) in Preterm NeonatesStatus: Terminated, Estimated PCD: 2020-05-20
Clinical trial
Randomized Trial of Two Analgesics in Elderly ED PatientsStatus: Withdrawn, Estimated PCD: 2026-07-30
Clinical trial
The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty; a Pilot StudyStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve GastrectomyStatus: Completed, Estimated PCD: 2022-11-11
Abstract
ADALIMUMAB IN COMBINATION WITH NON-METHOTREXATE CONVENTIONAL SYNTHETIC DISEASE MODIFYING RHEUMATIC DRUGS IN A CLINICAL TRIAL SETTING Org: Mount Sinai Hospital, University of Toronto, AbbVie, Inc., North Chicago, United States of America, North Chicago, IL, Albany School of Medicine,
Abstract
A PHASE IIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF TWO DIFFERENT DOSES OF CTLA4IG ADMINISTERED INTRAVENOUSLY TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITISOrg: Primus Pharmaceuticals, Bristol-Myers Squibb, Princeton Health, Rheumatology, Center of Rheumatology,
Abstract
A COMPARISON OF UPADACITINIB PLUS METHOTREXATE AND UPADACITINIB PLUS OTHER CSDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN ANALYSIS OF TWO PHASE 3 STUDIESOrg: Albany Medical College, Ghent University Hospital and Ghent University, Kantonsspital St Gallen, Universidade Federal do Paraná, Charité-Universitätsmedizin Berlin,
Abstract
ABATACEPT SUSTAINS INHIBITION OF RADIOGRAPHIC PROGRESSION OVER 2 YEARS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE (MTX): RESULTS FROM THE LONG-TERM EXTENSION (LTE) OF THE AIM TRIALOrg: SYNARC, Global Biometric Sciences, Bristol-Myers Squibb, Princeton, United States, Bristol-Myers Squibb, Albany Medical College,
Abstract
ACUTE AND LONG-TERM EFFICACY OF IL-1 INHIBITOR ANAKINRA IN IDIOPATHIC AND SECONDARY PERICARDITIS IN PATIENTS REFRACTORY OR INTOLERANT TO CONVENTIONAL THERAPYOrg: Albany Medical Center, Albany Medical College,
Abstract
ABATACEPT PROVIDES SIGNIFICANT AND SUSTAINED BENEFITS IN CLINICAL AND PATIENT-REPORTED OUTCOMES THROUGH 2 YRS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO METHOTREXATE (MTX): THE LONG-TERM EXTENSION (LTE) OF THE AIM TRIALOrg: Albany Medical College, The Center for Rheumatology, University of Leeds, Bristol-Myers Squibb, UZ KU Leuven,
Abstract
BING NEEL SYNDROME: AN UNKNOWN GCA MIMICKEROrg: Albany Medical Center, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Albany Medical College, United States of America,
Abstract
BARICITINIB, AN ORAL JANUS KINASE (JAK)1/JAK2 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO TNF INHIBITORS: RESULTS OF THE PHASE 3 RA-BEACON STUDY Org: Stanford University School of Medicine, Albany Medical College, Rheumazentrum Favoriten, East Penn Rheumatology, Eli Lilly & Company, Indianapolis, United States,